Ryo Matsunuma

745 total citations
43 papers, 382 citations indexed

About

Ryo Matsunuma is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Ryo Matsunuma has authored 43 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Public Health, Environmental and Occupational Health and 15 papers in Epidemiology. Recurrent topics in Ryo Matsunuma's work include Palliative Care and End-of-Life Issues (16 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Ryo Matsunuma is often cited by papers focused on Palliative Care and End-of-Life Issues (16 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Ryo Matsunuma collaborates with scholars based in Japan, United States and Austria. Ryo Matsunuma's co-authors include Yoshihiro Ohkuni, Nobuhiro Asai, Takuya Iwasaki, Kei Nakashima, Takashi Yamaguchi, Norihiro Kaneko, Kazuo Kasahara, Shinji Motojima, Tamao Nakashita and Masanori Mori and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Journal of Pain and Symptom Management.

In The Last Decade

Ryo Matsunuma

41 papers receiving 375 citations

Peers

Countries citing papers authored by Ryo Matsunuma

Since Specialization

Citations

This map shows the geographic impact of Ryo Matsunuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Matsunuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Matsunuma more than expected).

Fields of papers citing papers by Ryo Matsunuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Matsunuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Matsunuma. The network helps show where Ryo Matsunuma may publish in the future.

Co-authorship network of co-authors of Ryo Matsunuma

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Matsunuma. A scholar is included among the top collaborators of Ryo Matsunuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Matsunuma. Ryo Matsunuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current Management Options for Dyspnea in Cancer Patients 2023 ·Current Treatment Options in Oncology ·Masanori Mori, (unknown), Tomoo Ikari, Jun Kako, Takaaki Hasegawa, Ryo Matsunuma, Kozue Suzuki, Yoshinobu Matsuda, Hiroaki Watanabe, Tatsuya Morita, Takashi Yamaguchi	3
2	Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study 2023 ·Journal of Pain and Symptom Management ·Takashi Yamaguchi, Ryo Matsunuma, Yoshinobu Matsuda, Junichi Tasaki, Tomoo Ikari, (unknown), (unknown), Yusuke Takagi, (unknown), Kozue Suzuki, Shunsuke Oyamada, Keisuke Ariyoshi, (unknown), Masanori Mori	8
3	Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study 2023 ·Journal of Pain and Symptom Management ·Masanori Mori, Takashi Yamaguchi, Kozue Suzuki, Yoshinobu Matsuda, Ryo Matsunuma, Hiroaki Watanabe, Tomoo Ikari, Yoshihisa Matsumoto, Kengo Imai, Naosuke Yokomichi, (unknown), Toshihiro Yamauchi, (unknown), Satoshi Inoue, Akira Inoue, David Hui, Tatsuya Morita, Eriko Satomi	2
4	Malodour from oral malignant fungating wound: sprayed metronidazole – case report 2023 ·BMJ Supportive & Palliative Care ·(unknown), Ryo Matsunuma, (unknown), Madoka Ito, (unknown), (unknown), Takashi Yamaguchi	0
5	Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis 2023 ·International Journal of Clinical Oncology ·Yusuke Takagi, Junya Sato, Yoshihiro Yamamoto, Ryo Matsunuma, Hiroaki Watanabe, Masanori Mori, Takaaki Hasegawa, Yoshinobu Matsuda, Jun Kako, (unknown), Sho Goya, Hiroyuki Kohara, Takeo Nakayama, Takashi Yamaguchi	4
6	The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study 2022 ·Cancer Medicine ·Masanori Mori, Takashi Yamaguchi, Kozue Suzuki, Yoshinobu Matsuda, Ryo Matsunuma, Hiroaki Watanabe, Tomoo Ikari, Yoshihisa Matsumoto, Kengo Imai, Naosuke Yokomichi, (unknown), Toshihiro Yamauchi, (unknown), Satoshi Inoue, Akira Inoue, Tatsuya Morita, Eriko Satomi, (unknown)	7
7	Comprehensive Palliative Care Needs in Outpatients with Chronic Heart Failure: A Japanese Cross-Sectional Study 2022 ·SHILAP Revista de lepidopterología ·Ryo Matsunuma, Kensuke Matsumoto, Takashi Yamaguchi, Akihiro Sakashita, Yoshiyuki Kizawa	10
8	Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia 2022 ·Respiratory Investigation ·Nobuhiro Asai, Shinji Motojima, Yoshihiro Ohkuni, Ryo Matsunuma, Tamao Nakashita, Norihiro Kaneko, Hiroshige Mikamo	10
9	Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study 2021 ·Journal of Pain and Symptom Management ·Masanori Mori, Takashi Kawaguchi, Kengo Imai, Naosuke Yokomichi, Takashi Yamaguchi, Kozue Suzuki, Ryo Matsunuma, Hiroaki Watanabe, Isseki Maeda, Yoshihisa Matsumoto, Yoshinobu Matsuda, Tatsuya Morita	8
10	Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseases 2021 ·Respiratory Investigation ·Yoshinobu Matsuda, (unknown), (unknown), (unknown), Akira Inoue, (unknown), Ryo Matsunuma, Yuki Kataoka, Hideya Kitamura, Kensuke Kataoka, Hiroto Matsuoka, Akihiro Tokoro, Yoshikazu Inoue	1
11	Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians 2020 ·SHILAP Revista de lepidopterología ·Yoshinobu Matsuda, Ryo Matsunuma, Kozue Suzuki, Masanori Mori, Hiroaki Watanabe, Takashi Yamaguchi	3
12	Benzodiazepines for cancer dyspnoea: a nationwide survey of palliative care physicians 2019 ·BMJ Supportive & Palliative Care ·Yoshinobu Matsuda, Ryo Matsunuma, Kozue Suzuki, Masanori Mori, Hiroaki Watanabe, Takashi Yamaguchi	6
13	Patients with end-stage interstitial lung disease may have more problems with dyspnea than end-stage lung cancer patients 2016 ·Indian Journal of Palliative Care ·Ryo Matsunuma, Hazuki Takato, Yoshihiro Takeda, Satoshi Watanabe, Yuko Waseda, Shinya Murakami, Yukimitsu Kawaura, Kazuo Kasahara	13
14	Pleuroparenchymal fibroelastosis: Distinct pulmonary physiological features in nine patients 2015 ·Respiratory Investigation ·Satoshi Watanabe, Yuko Waseda, Hazuki Takato, Ryo Matsunuma, Takeshi Johkoh, Ryoko Egashira, Yoshinori Kawabata, Hiroko Ikeda, Masahide Yasui, Masaki Fujimura, Kazuo Kasahara	34
15	I-ROAD could be efficient in predicting severity of community-acquired pneumonia or healthcare-associated pneumonia 2014 ·Singapore Medical Journal ·Ryo Matsunuma, (unknown), Yoshihiro Ohkuni, Kei Nakashima, Takuya Iwasaki, Mahito Misawa, (unknown)	18
16	Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy 2012 ·Journal of Cancer Research and Therapeutics ·Nobuhiro Asai, Yoshihiro Ohkuni, Ryo Matsunuma, Kei Nakashima, Takuya Iwasaki, Norihiro Kaneko	11
17	The predictive rule for the management of hospital-acquired pneumonia in adults by the Japanese Respiratory Society, I-ROAD, could correctly estimate the severity of Pneumcystis Pneumonia without human immunodeficiency virus infection 2012 ·International Journal of Infectious Diseases ·(unknown), Yoshihiro Ohkuni, Ryo Matsunuma, Kei Nakashima, Tamao Nakashita, Yoshihito Otsuka, Norihiro Kaneko, Seiji Motojima, Masahiro Aoshima	1
18	Radiological features of pneumocystis pneumonia (PCP) without HIV 2011 ·European Respiratory Journal ·Nobuhiro Asai, Yoshihiro Ohkuni, Ryo Matsunuma, Yoshihito Otsuka, Norihiro Kaneko	1
19	Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease 2011 ·Journal of Infection and Chemotherapy ·Nobuhiro Asai, Yoshihiro Ohkuni, Takuya Iwasaki, Ryo Matsunuma, Kei Nakashima, Norihiro Kaneko, Yoshihito Otsuka	7
20	Clinical Stage I Lung Cancer in an Aging Population 2010 ·Haigan ·(unknown), (unknown), (unknown), (unknown), (unknown), Ryo Matsunuma, Nobuhiro Asai, (unknown), Norihiro Kaneko	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact